MENU
AVTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Avalo Therapeutics (AVTX) Ownership - Who owns Avalo Therapeutics?
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation... Show more
Industry: #Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
540 Gaither Road
Phone
+1 410 522-8707
Employees
19
Web
https://www.avalotx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
122.19M
P/E Ratio
1.42
Total Cash
113.26M
Projected Growth
N/A
Total Debt
679K
Revenue
441K
Risk (Beta)
0.73
Dividend Yield
N/A
Total Cash/Share
8.61
Total Debt/Equity
N/A
Revenue/Share
0.04 USD as % of share price
Fundamentals
AVTX
Capitalization
122M
P/E Ratio
1.42
Risk (Beta)
0.73
Dividend Yield
N/A
Total Cash
113M
Total Cash/Share
8.61
Total Debt
679K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.04%
Revenue
441K
ROE
N/A
Book Value
105M
P/B Ratio
1.17
Cash Flow
N/A
Earnings
12.99
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
11K
Current Ratio
12.44
Current Revenue Per Employee
13105.26
Dividends Per Share - Security
N/A
EBITDA
-59.78M
Float
N/A
Float - Current
N/A
Gross Income Margin
386.75
Revenue To Assets
-39.35
Shares Held By Institutions
53.3M
Shares Outstanding - Current
13.2M
Total Liabilities
22M
Total Volume MTD
N/A
Value
-1
Gain YTD
25.034
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
a clinical stage biopharmaceutical company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
540 Gaither Road
Phone
+1 410 522-8707
Employees
19
Web
https://www.avalotx.com